22UA.F
Price:
$89.45
Market Cap:
$22.47B
BioNTech SE is a biotechnology firm dedicated to the research, development, and marketing of immunotherapies for oncology and a spectrum of infectious diseases. Its diverse product pipeline features several FixVac candidates, including BNT111, currently undergoing Phase II clinical trials for advanced melanoma; BNT112, in Phase I/IIa development for prostate cancer; BNT113, progressing through Phase II for HPV-positive head and neck cancers; BNT114, in Phase I for triple-negative breast cancer; BNT115, also in Phase I for ovarian cancer; and BNT116, a preclinical asset targeting non-small cell lung cancer. Further expanding its oncology focus, BioNTech is advancing neoantigen-specific immuno...[Read more]
Industry
Biotechnology
IPO Date
2019-10-11
Stock Exchange
FSX
Ticker
22UA.F
According to BioNTech SE’s latest financial reports and current stock price. The company's current ROE is -9.16%. This represents a change of 295.09% compared to the average of -2.32% of the last 4 quarters.
The mean historical ROE of BioNTech SE over the last ten years is 24.96%. The current -9.16% ROE has changed -136.70% with respect to the historical average. Over the past ten years (40 quarters), 22UA.F's ROE was at its highest in in the June 2021 quarter at 50.84%. The ROE was at its lowest in in the September 2020 quarter at -22.64%.
Average
24.96%
Median
0.55%
Minimum
-36.31%
Maximum
173.75%
Discovering the peaks and valleys of BioNTech SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 173.75%
Minimum Annual Increase = -174.59%
Minimum Annual ROE = -36.31%
| Year | ROE | Change |
|---|---|---|
| 2025 | -5.68% | 65.69% |
| 2024 | -3.43% | -174.59% |
| 2023 | 4.60% | -90.23% |
| 2022 | 47.04% | -45.64% |
| 2021 | 86.54% | 7.71% |
| 2020 | 1.11% | -103.05% |
| 2019 | -36.31% | 101.24% |
| 2018 | -18.04% | -110.38% |
| 2017 | 173.75% | Infinity% |
The current ROE of BioNTech SE (22UA.F) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.50%
5-year avg
25.81%
10-year avg
24.96%
BioNTech SE’s ROE is less than Koninklijke Philips N.V. (10.05%), less than Genmab A/S (13.58%), less than Biogen Inc. (4.52%), greater than Bayer Aktiengesellschaft (-6.10%), greater than Moderna, Inc. (-39.20%), less than Coloplast A/S (19.69%), less than Fresenius SE & Co. KGaA (7.89%), less than Novavax, Inc. (159.85%), less than CureVac N.V. (23.04%), less than CureVac N.V. (23.04%),
| Company | ROE | Market cap |
|---|---|---|
| 10.05% | $21.88B | |
| 13.58% | $18.06B | |
| 4.52% | $24.48B | |
| -6.10% | $47.99B | |
| -39.20% | $48.90B | |
| 19.69% | $13.71B | |
| 7.89% | $24.57B | |
| 159.85% | $1.44B | |
| 23.04% | $879.52M | |
| 23.04% | $879.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioNTech SE's ROE?
How is the ROE calculated for BioNTech SE (22UA.F)?
What is the highest ROE for BioNTech SE (22UA.F)?
What is the 3-year average ROE for BioNTech SE (22UA.F)?
What is the 5-year average ROE for BioNTech SE (22UA.F)?
How does the current ROE for BioNTech SE (22UA.F) compare to its historical average?